Scientists identify an RNA molecule as a potential target for new Alzheimer's therapies

Scientists from the DZNE and University of Bonn have discovered that a modification of the protein amyloid beta causes it to aggregate and form plaques – a typical feature of Alzheimer's disease

Bonn/Tübingen, September15th 2011. Dr. Michela Deleidi, a scientist in Prof. Thomas Gasser’s research group at the DZNE site Tübingen and the Hertie Institute for Brain Research, received a Humboldt Research Fellowship for Postdoctoral Researchers. With the…

The Centres of Excellence in Neurodegeneration Research (CoEN) -initiative, an international funding partnership, announces investment in eight exciting new international research projects which will address key issues in neurodegenerative disease research. …

A joint research project on synaptic signal transmission will be initialized with a one-day symposium entitled "Synaptic Signals" on October 21st in Bonn. The aim of the project is to gain a better understanding of synaptic function of the hippocampal neurons.…

Bonn, September 2, 2011. The first "Hartwig Piepenbrock-DZNE Prize" for outstanding research in the field of neurodegenerative diseases will be awarded to the renowned Alzheimer researcher Prof. Konrad Beyreuther, Heidelberg University. The award honors…

German Researchers discover a new mechanism and a new treatment option for Alzheimer ’s disease

Bonn/Cologne, September 1st. The first conference on Aging and Neurodegeneration, organized by the German Center for Neurodegenerative Diseases (DZNE) and the Max Planck Institute for Biology of Ageing (MPI Age), will take place at Schloss Bensberg, Bergisch…

The DZNE Rostock / Greifswald in cooperation with the DZNE Witten organizes an international workshop on dementa care research entitled "Dementia care research - scientific evidence, current issues and future perspectives".Current developments in health care…